Philips Teams with University of Kentucky's UK HealthCare to Power State's only eICU Clinical Command Center

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and UK HealthCare, the clinical enterprise of the University of Kentucky, announced a collaboration to create Kentucky's only operating clinical command center for tele-critical care and operational optimization. Leveraging Philips' acute telehealth platform, eCareManager, the academic medical center is implementing a centralized virtual care model to help providers detect risk of patient deterioration so they can intervene earlier and help improve care outcomes for the organization’s sickest patients.

Philips' eICU Program is built around eCareManager, which uses advanced analytics and AI to synthesize patient data and deliver actionable insights to support proactive care. Using this comprehensive system, University of Kentucky (UK) HealthCare will provide 24/7 remote monitoring and access to specialists for patients in the neurological, trauma, surgery, post-anesthesia care, medical intensive care, emergency department and cardiovascular patient care venues. The institution also aims to improve bed utilization and patient flow across its 160 ICU beds at two hospitals.

Since COVID-19 is predominantly a respiratory illness, patients with more severe cases may require ICU care. eCareManager acuity based scoring tools monitor a patient's condition to detect subtle deteriorations prior to becoming adverse events. Predictive AI-enabled algorithms such as Sentry Score, designed to focus on a patients cardiovascular and Respiratory systems, provide clinicians in the telehealth center with predictive insights into those patients with the highest probability of requiring an intervention in the next 60 minutes. As bed availability and critical decisions on patient throughput are required, eCareManager integrates as part of its Clinical Performance Applications Suite the Discharge Readiness Score, a predictive algorithm that provides clinicians objective scoring on a patients risk of death or readmission within 48 hours of a planned discharge.

"In these most challenging times, healthcare organizations need digital technology to enhance the patient experience, improve health outcomes, lower the cost of care, and enhance the work-life of care providers now more than ever before," said Roy Jakobs, Chief Business Leader Connected Care, member of the Executive Committee at Royal Philips. "Partnering with UK HealthCare to address these concerns for the sickest patients demonstrates Philips’ commitment to deliver unique approaches to help meet the demand of healthcare's greatest challenges."

"This partnership is vital to our foundational vision of high value care. Leveraging technology and highly developed clinical algorithms will aid our progressive high-performance health system," said Dr. Colleen Swartz, Vice President for Hospital Operations at UK HealthCare. "Especially during this time of increased need for very specific isolation and care models in managing COVID-19 patients, the application of virtual monitoring will aid our teams in care provision. Philips is an essential partner in our efforts to progress care across the state."

First of its kind outcomes-based partnership

As the shift to value-based care and reimbursement is increasingly dependent upon measurable outcomes, Philips and UK HealthCare plan to measure Key Performance Indicator metrics and will work together to identify improvement areas and generate mutual value. The partnership between UK HealthCare and Philips is a pioneering model in ICU telehealth, focused on addressing the quadruple aim by measuring outcomes across both clinical and operational value. The Philips eICU Program is uniquely positioned to partner with customers on innovative outcomes-based models in acute care. With the goal of improving patient care, clinical efficiencies, and ICU quality best practices through telehealth, eICU Program outcomes are demonstrated in peer reviewed publications.

As health systems seek to improve health outcomes, eICU programs enable a co-located team of intensivists and critical care nurses to remotely monitor patients in the ICU regardless of patient location, helping to optimize care costs and enhance clinician and patient satisfaction. Intensivists and nurses based in a telehealth eICU hub are supported by high-definition cameras and communications technology, predictive analytics, data visualization and advanced reporting capabilities to support their frontline colleagues.

Dashboards bring together data from the EMR and patient monitors on the ICU floor, where advanced algorithms alert to signs of deterioration helping the care team to proactively intervene at an earlier stage. eICU programs have been the subject of peer-reviewed literature since 2002, with outcomes data presenting clinical benefits in mortality reduction and operational systems benefits through increased throughput of ICU patients by reducing ICU patient length of stay [1].

Philips is the global leader in centralized tele-critical care. More than 20% of US adult ICU beds and 1 in 8 adult ICU patients are monitored by a 24/7 continuous demand model powered by the eICU Program, which combines A/V technology, predictive analytics, data visualization and advanced reporting capabilities [2, 3]. The core of this program is Philips eCareManager software, which delivers need-to-know information to caregivers, empowering them to care for the patients in a more proactive manner.

Philips tele-critical care platforms are available around the globe with clinical informatics applications supporting bedside, unit and virtual care delivery models. For more information on how Philips is addressing the Coronavirus globally, please visit the Philips centralized COVID-19 hub.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.

About UK HealthCare

UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is 9,000 people - physicians, nurses, pharmacists and other healthcare professionals - all dedicated to providing the most advanced, most effective care available, not just in Kentucky but anywhere. UK HealthCare is the power of advanced medicine.

1. Lilly CM, et al. A Multi-Center Study of ICU Telemedicine Reengineering of Adult Critical Care. CHEST. 2014 Mar 1; 145(3): 500-7.
2. Representative of the total Philips eICU licensed beds as a percentage coverage relative to total US adult ICU beds
3. Derived from SCCM Adult ICU admission statistic and compared to eCareManager eRI annual monitored patients https://www.sccm.org/Communications/Critical-Care-Statistics About Royal Philips

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...